Covid-19 Vaccine

Records for this ingredient, by country (identity only).

ATC — · 2 markets · 65 records

Covid-19 Vaccine 2 markets · 65 records Forms
Filters
MarketGB 60EU 1

GB 60 records · 9 shown of 9 Source NHSBSA dm+d · Data as of 2026-10-19

  • 0.3 mL per mL / per unit basis not statedinjectionComirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vialsComirnaty COVID-19 mRNA Vaccine ready to use 30micrograms/0.3ml dose dispersion for injection multidose vials、Comirnaty JN.1 Children 5-11 years COVID-19 mRNA Vaccine 10micrograms/0.3ml dose dispersion for injection single dose vials、Comirnaty JN.1 Children 6 months - 4 years COVID-19 mRNA Vaccine 3micrograms/0.3ml dose concentrate for dispersion for injection multidose vials、Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials、Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection pre-filled syringes、Comirnaty KP.2 adults and adolescents from 12 years COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials、Comirnaty KP.2 adults and adolescents from 12 years COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection pre-filled syringes、Comirnaty LP.8.1 adults and adolescents from 12 years COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection pre-filled syringes +9
  • 0.5 mL per mL / per unit basis not statedinjectionBimervax LP.8.1 COVID-19 Vaccine (recombinant, adjuvanted) 40micrograms/0.5ml dose emulsion for injection vialsCoronaVac COVID-19 Vaccine (adjuvanted) 600U/0.5ml dose suspension for injection vials、COVID-19 Vaccine Bimervax (recombinant, adjuvanted) 40micrograms/0.5ml dose emulsion for injection multidose vials、COVID-19 Vaccine Covaxin (NIV-2020-770 inactivated) 6micrograms/0.5ml dose suspension for injection multidose vials、COVID-19 Vaccine Covaxin (NIV-2020-770 inactivated) 6micrograms/0.5ml dose suspension for injection vials、COVID-19 Vaccine Covovax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials、COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials、COVID-19 Vaccine Medicago (CoVLP) 3.75micrograms/0.5ml dose emulsion for injection multidose vials、COVID-19 Vaccine Moderna (mRNA-1273.214) 50micrograms/0.5ml dose dispersion for injection vials +8
  • 0.5 mL per mL / per unit basis not statedliquidCOVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vialsCOVID-19 Vaccine Convidecia (Adenovirus Type 5 Vector [recombinant]) 40,000,000,000 viral particles/0.5ml dose solution for injection vials、COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials、COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection vials、COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms/2.5micrograms/0.5ml dose emulsion for injection multidose vials、COVID-19 Vaccine Sanofi (CoV2 preS dTM monovalent D614 [recombinant]) 5micrograms/0.5ml dose suspension for injection multidose vials、COVID-19 Vaccine Sputnik V Component I (recombinant serotype 26 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection multidose vials、COVID-19 Vaccine Sputnik V Component I (recombinant serotype 26 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials、COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection multidose vials +4
  • 0.2 mL per mL / per unit basis not statedliquidComirnaty Children 5-11 years COVID-19 mRNA Vaccine 10micrograms/0.2ml dose concentrate for dispersion for injection multidose vialsComirnaty Children 6 months - 4 years COVID-19 mRNA Vaccine 3micrograms/0.2ml dose concentrate for dispersion for injection multidose vials、Comirnaty Omicron XBB.1.5 Children 6 months - 4 years COVID-19 mRNA Vaccine 3micrograms/0.2ml dose concentrate for dispersion for injection multidose vials
  • 0.1 mg per mL / per unit basis not statedinjectionCOVID-19 Vaccine Spikevax 0 (Zero)/O (Omicron) 0.1mg/ml dispersion for injection multidose vialsCOVID-19 Vaccine Spikevax Original/Omicron BA.4/BA.5 dispersion for injection 0.1mg/ml multidose vials、Spikevax JN.1 COVID-19 mRNA Vaccine 0.1mg/ml dispersion for injection multidose vials
  • 0.1 mg/1 mLinjectionSpikevax LP.8.1 COVID-19 mRNA Vaccine 0.1mg/1ml dispersion for injection multidose vialsSpikevax XBB.1.5 COVID-19 mRNA Vaccine 0.1mg/1ml dispersion for injection multidose vials、Spikevax XFG COVID-19 mRNA Vaccine 0.1mg/1ml dispersion for injection multidose vials
  • 0.25 mL per mL / per unit basis not statedinjectionCOVID-19 Vaccine Moderna (mRNA-1273.529) 50micrograms/0.25ml dose solution for injection multidose vials
  • 0.2 mL per mL / per unit basis not statedinjectionCOVID-19 Vaccine Moderna (mRNA-1283.222) 10micrograms/0.2ml dose solution for injection vials
  • 0.1 mg/0.5 mLinjection · extended-releaseSpikevax COVID-19 mRNA (nucleoside modified) Vaccine 0.1mg/0.5ml dose dispersion for injection multidose vials

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.